Novartis

Shuttle Pharmaceuticals (NASDAQ: SHPH) is doubling down on its mission to revolutionize cancer treatment with radiation therapy. In just a…

Shuttle Pharmaceuticals (NASDAQ: SHPH) is advancing its mission to revolutionize prostate cancer treatment. On April 10, 2025, the company announced…